APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oligonucleotide Pool Library

North America occupied the largest market share with about 40%. It was followed by Europe，with 30%. Integrated DNA Technologies, Illumnia, Agilent, Sigma-aldrich and Eurofins Genomics are the top 5 manufacturers of global Oligonucleotide Pool Library market, had a more than 40% combined market share.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

North America occupied the largest market share with about 40%. It was followed by Europe，with 30%. Integrated DNA Technologies, Illumnia, Agilent, Sigma-aldrich and Eurofins Genomics are the top 5 manufacturers of global Oligonucleotide Pool Library market, had a more than 40% combined market share.

Selected research

Market Analysis & Forecast

Global Oligonucleotide Pool Library Market Analysis and Forecast 2026-2032

26 December 2025190 pages

Choose your research edition.

Industry ResearchOligonucleotide Pool Library Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Oligonucleotide Pool Library Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Oligonucleotide Pool Library Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oligonucleotide Pool Library Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Oligonucleotide Pool Library Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

North America occupied the largest market share with about 40%. It was followed by Europe，with 30%. Integrated DNA Technologies, Illumnia, Agilent, Sigma-aldrich and Eurofins Genomics are the top 5 manufacturers of global Oligonucleotide Pool Library market, had a more than 40% combined market share.

North America occupied the largest market share with about 40%. It was followed by Europe，with 30%. Integrated DNA Technologies, Illumnia, Agilent, Sigma-aldrich and Eurofins Genomics are the top 5 manufacturers of global Oligonucleotide Pool Library market, and they had a more than 40% combined market share.

Report Includes

Read the full market overview

This report presents an overview of global market for Oligonucleotide Pool Library, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Oligonucleotide Pool Library, also provides the revenue of main regions and countries. Of the upcoming market potential for Oligonucleotide Pool Library, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oligonucleotide Pool Library revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Oligonucleotide Pool Library market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Oligonucleotide Pool Library revenue, projected growth trends, production technology, application and end-user industry.

Oligonucleotide Pool Library Segment by Company

Agilent

Eurogentec S.A

Sigmaaldrich

Illumnia

L.G.C Biosearch Technologies

Eurofins Genomics

Roche NimbleGe

Integrated DNA Technologies

Nitto Denko Avecia Inc

General Biosystems

MYcroarray

Twist Bioscience

CustomArray

LC Sciences

Creative Biogene

Oligonucleotide Pool Library Segment by Type

DNA Oligos

RNA Oligos

Oligonucleotide Pool Library Segment by Application

Target Capture

CRISPR/Cas9 Designs

Gene Synthesis

Library Preparation

Others

Oligonucleotide Pool Library Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oligonucleotide Pool Library market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oligonucleotide Pool Library and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oligonucleotide Pool Library.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Oligonucleotide Pool Library in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Oligonucleotide Pool Library company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oligonucleotide Pool Library revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Oligonucleotide Pool Library Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. DNA Oligos Major Player Table 3. RNA Oligos Major Player Table 4. Global Oligonucleotide Pool Library Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Target Capture Major Player Table 6. CRISPR/Cas9 Designs Major Player Table 7. Gene Synthesis Major Player Table 8. Library Preparation Major Player Table 9. Others Major Player Table 10. Oligonucleotide Pool Library Industry Trends Table 11. Oligonucleotide Pool Library Industry Drivers Table 12. Oligonucleotide Pool Library Industry Opportunities and Challenges Table 13. Oligonucleotide Pool Library Industry Restraints Table 14. Global Oligonucleotide Pool Library Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Oligonucleotide Pool Library Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Oligonucleotide Pool Library Market Share by Region (2021-2026) Table 17. Global Oligonucleotide Pool Library Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Oligonucleotide Pool Library Market Share by Region (2027-2032) Table 19. Global Oligonucleotide Pool Library Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Oligonucleotide Pool Library Revenue Market Share by Players (2021-2026) Table 21. Global Oligonucleotide Pool Library Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Oligonucleotide Pool Library Key Players Headquarters & Area Served Table 23. Global Oligonucleotide Pool Library Players, Product Type & Application Table 24. Global Oligonucleotide Pool Library Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Oligonucleotide Pool Library by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Oligonucleotide Pool Library Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Oligonucleotide Pool Library Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Oligonucleotide Pool Library Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Oligonucleotide Pool Library Revenue Market Share by Type (2021-2026) Table 31. Global Oligonucleotide Pool Library Revenue Market Share by Type (2027-2032) Table 32. Global Oligonucleotide Pool Library Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Oligonucleotide Pool Library Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Oligonucleotide Pool Library Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Oligonucleotide Pool Library Revenue Market Share by Application (2021-2026) Table 36. Global Oligonucleotide Pool Library Revenue Market Share by Application (2027-2032) Table 37. Agilent Company Information Table 38. Agilent Business Overview Table 39. Agilent Oligonucleotide Pool Library Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Agilent Oligonucleotide Pool Library Product Portfolio Table 41. Agilent Recent Development Table 42. Eurogentec S.A Company Information Table 43. Eurogentec S.A Business Overview Table 44. Eurogentec S.A Oligonucleotide Pool Library Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Eurogentec S.A Oligonucleotide Pool Library Product Portfolio Table 46. Eurogentec S.A Recent Development Table 47. Sigmaaldrich Company Information Table 48. Sigmaaldrich Business Overview Table 49. Sigmaaldrich Oligonucleotide Pool Library Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Sigmaaldrich Oligonucleotide Pool Library Product Portfolio Table 51. Sigmaaldrich Recent Development Table 52. Illumnia Company Information Table 53. Illumnia Business Overview Table 54. Illumnia Oligonucleotide Pool Library Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Illumnia Oligonucleotide Pool Library Product Portfolio Table 56. Illumnia Recent Development Table 57. L.G.C Biosearch Technologies Company Information Table 58. L.G.C Biosearch Technologies Business Overview Table 59. L.G.C Biosearch Technologies Oligonucleotide Pool Library Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. L.G.C Biosearch Technologies Oligonucleotide Pool Library Product Portfolio Table 61. L.G.C Biosearch Technologies Recent Development Table 62. Eurofins Genomics Company Information Table 63. Eurofins Genomics Business Overview Table 64. Eurofins Genomics Oligonucleotide Pool Library Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Eurofins Genomics Oligonucleotide Pool Library Product Portfolio Table 66. Eurofins Genomics Recent Development Table 67. Roche NimbleGe Company Information Table 68. Roche NimbleGe Business Overview Table 69. Roche NimbleGe Oligonucleotide Pool Library Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Roche NimbleGe Oligonucleotide Pool Library Product Portfolio Table 71. Roche NimbleGe Recent Development Table 72. Integrated DNA Technologies Company Information Table 73. Integrated DNA Technologies Business Overview Table 74. Integrated DNA Technologies Oligonucleotide Pool Library Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Integrated DNA Technologies Oligonucleotide Pool Library Product Portfolio Table 76. Integrated DNA Technologies Recent Development Table 77. Nitto Denko Avecia Inc Company Information Table 78. Nitto Denko Avecia Inc Business Overview Table 79. Nitto Denko Avecia Inc Oligonucleotide Pool Library Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Nitto Denko Avecia Inc Oligonucleotide Pool Library Product Portfolio Table 81. Nitto Denko Avecia Inc Recent Development Table 82. General Biosystems Company Information Table 83. General Biosystems Business Overview Table 84. General Biosystems Oligonucleotide Pool Library Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. General Biosystems Oligonucleotide Pool Library Product Portfolio Table 86. General Biosystems Recent Development Table 87. MYcroarray Company Information Table 88. MYcroarray Business Overview Table 89. MYcroarray Oligonucleotide Pool Library Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 90. MYcroarray Oligonucleotide Pool Library Product Portfolio Table 91. MYcroarray Recent Development Table 92. Twist Bioscience Company Information Table 93. Twist Bioscience Business Overview Table 94. Twist Bioscience Oligonucleotide Pool Library Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 95. Twist Bioscience Oligonucleotide Pool Library Product Portfolio Table 96. Twist Bioscience Recent Development Table 97. CustomArray Company Information Table 98. CustomArray Business Overview Table 99. CustomArray Oligonucleotide Pool Library Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 100. CustomArray Oligonucleotide Pool Library Product Portfolio Table 101. CustomArray Recent Development Table 102. LC Sciences Company Information Table 103. LC Sciences Business Overview Table 104. LC Sciences Oligonucleotide Pool Library Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 105. LC Sciences Oligonucleotide Pool Library Product Portfolio Table 106. LC Sciences Recent Development Table 107. Creative Biogene Company Information Table 108. Creative Biogene Business Overview Table 109. Creative Biogene Oligonucleotide Pool Library Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 110. Creative Biogene Oligonucleotide Pool Library Product Portfolio Table 111. Creative Biogene Recent Development Table 112. North America Oligonucleotide Pool Library Revenue by Type (2021-2026) & (US$ Million) Table 113. North America Oligonucleotide Pool Library Revenue by Type (2027-2032) & (US$ Million) Table 114. North America Oligonucleotide Pool Library Revenue by Application (2021-2026) & (US$ Million) Table 115. North America Oligonucleotide Pool Library Revenue by Application (2027-2032) & (US$ Million) Table 116. North America Oligonucleotide Pool Library Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. North America Oligonucleotide Pool Library Revenue by Country (2021-2026) & (US$ Million) Table 118. North America Oligonucleotide Pool Library Revenue by Country (US$ Million) & (2027-2032) Table 119. Europe Oligonucleotide Pool Library Revenue by Type (2021-2026) & (US$ Million) Table 120. Europe Oligonucleotide Pool Library Revenue by Type (2027-2032) & (US$ Million) Table 121. Europe Oligonucleotide Pool Library Revenue by Application (2021-2026) & (US$ Million) Table 122. Europe Oligonucleotide Pool Library Revenue by Application (2027-2032) & (US$ Million) Table 123. Europe Oligonucleotide Pool Library Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Europe Oligonucleotide Pool Library Revenue by Country (2021-2026) & (US$ Million) Table 125. Europe Oligonucleotide Pool Library Revenue by Country (US$ Million) & (2027-2032) Table 126. China Oligonucleotide Pool Library Revenue by Type (2021-2026) & (US$ Million) Table 127. China Oligonucleotide Pool Library Revenue by Type (2027-2032) & (US$ Million) Table 128. China Oligonucleotide Pool Library Revenue by Application (2021-2026) & (US$ Million) Table 129. China Oligonucleotide Pool Library Revenue by Application (2027-2032) & (US$ Million) Table 130. Asia Oligonucleotide Pool Library Revenue by Type (2021-2026) & (US$ Million) Table 131. Asia Oligonucleotide Pool Library Revenue by Type (2027-2032) & (US$ Million) Table 132. Asia Oligonucleotide Pool Library Revenue by Application (2021-2026) & (US$ Million) Table 133. Asia Oligonucleotide Pool Library Revenue by Application (2027-2032) & (US$ Million) Table 134. Asia Oligonucleotide Pool Library Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 135. Asia Oligonucleotide Pool Library Revenue by Region (US$ Million) & (2021-2026) Table 136. Asia Oligonucleotide Pool Library Revenue by Region (US$ Million) & (2027-2032) Table 137. SAMEA Oligonucleotide Pool Library Revenue by Type (2021-2026) & (US$ Million) Table 138. SAMEA Oligonucleotide Pool Library Revenue by Type (2027-2032) & (US$ Million) Table 139. SAMEA Oligonucleotide Pool Library Revenue by Application (2021-2026) & (US$ Million) Table 140. SAMEA Oligonucleotide Pool Library Revenue by Application (2027-2032) & (US$ Million) Table 141. SAMEA Oligonucleotide Pool Library Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. SAMEA Oligonucleotide Pool Library Revenue by Country (2021-2026) & (US$ Million) Table 143. SAMEA Oligonucleotide Pool Library Revenue by Country (US$ Million) & (2027-2032) Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Oligonucleotide Pool Library Image Figure 2. Global Oligonucleotide Pool Library Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oligonucleotide Pool Library Market Size Share 2021 VS 2025 VS 2032 Figure 4. DNA Oligos Image Figure 5. RNA Oligos Image Figure 6. Global Oligonucleotide Pool Library Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Oligonucleotide Pool Library Market Size Share 2021 VS 2025 VS 2032 Figure 8. Target Capture Image Figure 9. CRISPR/Cas9 Designs Image Figure 10. Gene Synthesis Image Figure 11. Library Preparation Image Figure 12. Others Image Figure 13. Global Oligonucleotide Pool Library Market Size (US$ Million) & (2021-2032) Figure 14. Global Oligonucleotide Pool Library Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Oligonucleotide Pool Library Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Oligonucleotide Pool Library Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Oligonucleotide Pool Library Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Oligonucleotide Pool Library Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Oligonucleotide Pool Library Revenue Market Share by Type (2021-2032) Figure 21. Global Oligonucleotide Pool Library Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Oligonucleotide Pool Library Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Oligonucleotide Pool Library Revenue Market Share by Application (2021-2032) Figure 24. North America Oligonucleotide Pool Library Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Oligonucleotide Pool Library Revenue Share by Type (2021-2032) Figure 26. North America Oligonucleotide Pool Library Revenue Share by Application (2021-2032) Figure 27. North America Oligonucleotide Pool Library Revenue Share by Country (2021-2032) Figure 28. United States Oligonucleotide Pool Library Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Oligonucleotide Pool Library Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Oligonucleotide Pool Library Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Oligonucleotide Pool Library Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Oligonucleotide Pool Library Revenue Share by Type (2021-2032) Figure 33. Europe Oligonucleotide Pool Library Revenue Share by Application (2021-2032) Figure 34. Europe Oligonucleotide Pool Library Revenue Share by Country (2021-2032) Figure 35. Germany Oligonucleotide Pool Library Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Oligonucleotide Pool Library Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Oligonucleotide Pool Library Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Oligonucleotide Pool Library Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Oligonucleotide Pool Library Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Oligonucleotide Pool Library Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Oligonucleotide Pool Library Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Oligonucleotide Pool Library Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Oligonucleotide Pool Library Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Oligonucleotide Pool Library Revenue Share by Type (2021-2032) Figure 45. China Oligonucleotide Pool Library Revenue Share by Application (2021-2032) Figure 46. Asia Oligonucleotide Pool Library Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Oligonucleotide Pool Library Revenue Share by Type (2021-2032) Figure 48. Asia Oligonucleotide Pool Library Revenue Share by Application (2021-2032) Figure 49. Asia Oligonucleotide Pool Library Revenue Share by Region (2021-2032) Figure 50. Japan Oligonucleotide Pool Library Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Oligonucleotide Pool Library Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Oligonucleotide Pool Library Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Oligonucleotide Pool Library Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Oligonucleotide Pool Library Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Oligonucleotide Pool Library Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Oligonucleotide Pool Library Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Oligonucleotide Pool Library Revenue Share by Type (2021-2032) Figure 58. SAMEA Oligonucleotide Pool Library Revenue Share by Application (2021-2032) Figure 59. SAMEA Oligonucleotide Pool Library Revenue Share by Country (2021-2032) Figure 60. Brazil Oligonucleotide Pool Library Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Oligonucleotide Pool Library Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Oligonucleotide Pool Library Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Oligonucleotide Pool Library Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Oligonucleotide Pool Library Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Oligonucleotide Pool Library Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Oligonucleotide Pool Library Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Oligonucleotide Pool Library Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Oligonucleotide Pool Library Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Oligonucleotide Pool Library Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Oligonucleotide Pool Library Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • DNA Oligos
  • RNA Oligos
Applications
  • Target Capture
  • CRISPR/Cas9 Designs
  • Gene Synthesis
  • Library Preparation
  • Others
Companies covered
  • Agilent
  • Eurogentec S.A
  • Sigmaaldrich
  • Illumnia
  • L.G.C Biosearch Technologies
  • Eurofins Genomics
  • Roche NimbleGe
  • Integrated DNA Technologies
  • Nitto Denko Avecia Inc
  • General Biosystems
  • MYcroarray
  • Twist Bioscience
  • CustomArray
  • LC Sciences
  • Creative Biogene

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Oligonucleotide Pool Library Market by Type
  3. 1.2.1 Global Oligonucleotide Pool Library Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 DNA Oligos
  5. 1.2.3 RNA Oligos
  6. 1.3 Oligonucleotide Pool Library Market by Application
  7. 1.3.1 Global Oligonucleotide Pool Library Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Target Capture
  9. 1.3.3 CRISPR/Cas9 Designs
  10. 1.3.4 Gene Synthesis
  11. 1.3.5 Library Preparation
  12. 1.3.6 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Oligonucleotide Pool Library Market Dynamics
  1. 2.1 Oligonucleotide Pool Library Industry Trends
  2. 2.2 Oligonucleotide Pool Library Industry Drivers
  3. 2.3 Oligonucleotide Pool Library Industry Opportunities and Challenges
  4. 2.4 Oligonucleotide Pool Library Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Oligonucleotide Pool Library Market Perspective (2021-2032)
  2. 3.2 Global Oligonucleotide Pool Library Growth Trends by Region
  3. 3.2.1 Global Oligonucleotide Pool Library Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Oligonucleotide Pool Library Market Size by Region (2021-2026)
  5. 3.2.3 Global Oligonucleotide Pool Library Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Oligonucleotide Pool Library Revenue by Players
  2. 4.1.1 Global Oligonucleotide Pool Library Revenue by Players (2021-2026)
  3. 4.1.2 Global Oligonucleotide Pool Library Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Oligonucleotide Pool Library Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Oligonucleotide Pool Library Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Oligonucleotide Pool Library Key Players Headquarters & Area Served
  7. 4.4 Global Oligonucleotide Pool Library Players, Product Type & Application
  8. 4.5 Global Oligonucleotide Pool Library Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Oligonucleotide Pool Library Market CR5 and HHI
  11. 4.6.3 2025 Oligonucleotide Pool Library Tier 1, Tier 2, and Tier 3
5 Oligonucleotide Pool Library Market Size by Type
  1. 5.1 Global Oligonucleotide Pool Library Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Oligonucleotide Pool Library Revenue by Type (2021-2032)
  3. 5.3 Global Oligonucleotide Pool Library Revenue Market Share by Type (2021-2032)
6 Oligonucleotide Pool Library Market Size by Application
  1. 6.1 Global Oligonucleotide Pool Library Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Oligonucleotide Pool Library Revenue by Application (2021-2032)
  3. 6.3 Global Oligonucleotide Pool Library Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Agilent
  2. 7.1.1 Agilent Company Information
  3. 7.1.2 Agilent Business Overview
  4. 7.1.3 Agilent Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Agilent Oligonucleotide Pool Library Product Portfolio
  6. 7.1.5 Agilent Recent Developments
  7. 7.2 Eurogentec S.A
  8. 7.2.1 Eurogentec S.A Company Information
  9. 7.2.2 Eurogentec S.A Business Overview
  10. 7.2.3 Eurogentec S.A Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Eurogentec S.A Oligonucleotide Pool Library Product Portfolio
  12. 7.2.5 Eurogentec S.A Recent Developments
  13. 7.3 Sigmaaldrich
  14. 7.3.1 Sigmaaldrich Company Information
  15. 7.3.2 Sigmaaldrich Business Overview
  16. 7.3.3 Sigmaaldrich Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Sigmaaldrich Oligonucleotide Pool Library Product Portfolio
  18. 7.3.5 Sigmaaldrich Recent Developments
  19. 7.4 Illumnia
  20. 7.4.1 Illumnia Company Information
  21. 7.4.2 Illumnia Business Overview
  22. 7.4.3 Illumnia Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Illumnia Oligonucleotide Pool Library Product Portfolio
  24. 7.4.5 Illumnia Recent Developments
  25. 7.5 L.G.C Biosearch Technologies
  26. 7.5.1 L.G.C Biosearch Technologies Company Information
  27. 7.5.2 L.G.C Biosearch Technologies Business Overview
  28. 7.5.3 L.G.C Biosearch Technologies Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  29. 7.5.4 L.G.C Biosearch Technologies Oligonucleotide Pool Library Product Portfolio
  30. 7.5.5 L.G.C Biosearch Technologies Recent Developments
  31. 7.6 Eurofins Genomics
  32. 7.6.1 Eurofins Genomics Company Information
  33. 7.6.2 Eurofins Genomics Business Overview
  34. 7.6.3 Eurofins Genomics Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Eurofins Genomics Oligonucleotide Pool Library Product Portfolio
  36. 7.6.5 Eurofins Genomics Recent Developments
  37. 7.7 Roche NimbleGe
  38. 7.7.1 Roche NimbleGe Company Information
  39. 7.7.2 Roche NimbleGe Business Overview
  40. 7.7.3 Roche NimbleGe Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Roche NimbleGe Oligonucleotide Pool Library Product Portfolio
  42. 7.7.5 Roche NimbleGe Recent Developments
  43. 7.8 Integrated DNA Technologies
  44. 7.8.1 Integrated DNA Technologies Company Information
  45. 7.8.2 Integrated DNA Technologies Business Overview
  46. 7.8.3 Integrated DNA Technologies Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Integrated DNA Technologies Oligonucleotide Pool Library Product Portfolio
  48. 7.8.5 Integrated DNA Technologies Recent Developments
  49. 7.9 Nitto Denko Avecia Inc
  50. 7.9.1 Nitto Denko Avecia Inc Company Information
  51. 7.9.2 Nitto Denko Avecia Inc Business Overview
  52. 7.9.3 Nitto Denko Avecia Inc Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Nitto Denko Avecia Inc Oligonucleotide Pool Library Product Portfolio
  54. 7.9.5 Nitto Denko Avecia Inc Recent Developments
  55. 7.10 General Biosystems
  56. 7.10.1 General Biosystems Company Information
  57. 7.10.2 General Biosystems Business Overview
  58. 7.10.3 General Biosystems Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  59. 7.10.4 General Biosystems Oligonucleotide Pool Library Product Portfolio
  60. 7.10.5 General Biosystems Recent Developments
  61. 7.11 MYcroarray
  62. 7.11.1 MYcroarray Company Information
  63. 7.11.2 MYcroarray Business Overview
  64. 7.11.3 MYcroarray Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  65. 7.11.4 MYcroarray Oligonucleotide Pool Library Product Portfolio
  66. 7.11.5 MYcroarray Recent Developments
  67. 7.12 Twist Bioscience
  68. 7.12.1 Twist Bioscience Company Information
  69. 7.12.2 Twist Bioscience Business Overview
  70. 7.12.3 Twist Bioscience Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Twist Bioscience Oligonucleotide Pool Library Product Portfolio
  72. 7.12.5 Twist Bioscience Recent Developments
  73. 7.13 CustomArray
  74. 7.13.1 CustomArray Company Information
  75. 7.13.2 CustomArray Business Overview
  76. 7.13.3 CustomArray Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  77. 7.13.4 CustomArray Oligonucleotide Pool Library Product Portfolio
  78. 7.13.5 CustomArray Recent Developments
  79. 7.14 LC Sciences
  80. 7.14.1 LC Sciences Company Information
  81. 7.14.2 LC Sciences Business Overview
  82. 7.14.3 LC Sciences Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  83. 7.14.4 LC Sciences Oligonucleotide Pool Library Product Portfolio
  84. 7.14.5 LC Sciences Recent Developments
  85. 7.15 Creative Biogene
  86. 7.15.1 Creative Biogene Company Information
  87. 7.15.2 Creative Biogene Business Overview
  88. 7.15.3 Creative Biogene Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Creative Biogene Oligonucleotide Pool Library Product Portfolio
  90. 7.15.5 Creative Biogene Recent Developments
8 North America
  1. 8.1 North America Oligonucleotide Pool Library Revenue (2021-2032)
  2. 8.2 North America Oligonucleotide Pool Library Revenue by Type (2021-2032)
  3. 8.2.1 North America Oligonucleotide Pool Library Revenue by Type (2021-2026)
  4. 8.2.2 North America Oligonucleotide Pool Library Revenue by Type (2027-2032)
  5. 8.3 North America Oligonucleotide Pool Library Revenue Share by Type (2021-2032)
  6. 8.4 North America Oligonucleotide Pool Library Revenue by Application (2021-2032)
  7. 8.4.1 North America Oligonucleotide Pool Library Revenue by Application (2021-2026)
  8. 8.4.2 North America Oligonucleotide Pool Library Revenue by Application (2027-2032)
  9. 8.5 North America Oligonucleotide Pool Library Revenue Share by Application (2021-2032)
  10. 8.6 North America Oligonucleotide Pool Library Revenue by Country
  11. 8.6.1 North America Oligonucleotide Pool Library Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Oligonucleotide Pool Library Revenue by Country (2021-2026)
  13. 8.6.3 North America Oligonucleotide Pool Library Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Oligonucleotide Pool Library Revenue (2021-2032)
  2. 9.2 Europe Oligonucleotide Pool Library Revenue by Type (2021-2032)
  3. 9.2.1 Europe Oligonucleotide Pool Library Revenue by Type (2021-2026)
  4. 9.2.2 Europe Oligonucleotide Pool Library Revenue by Type (2027-2032)
  5. 9.3 Europe Oligonucleotide Pool Library Revenue Share by Type (2021-2032)
  6. 9.4 Europe Oligonucleotide Pool Library Revenue by Application (2021-2032)
  7. 9.4.1 Europe Oligonucleotide Pool Library Revenue by Application (2021-2026)
  8. 9.4.2 Europe Oligonucleotide Pool Library Revenue by Application (2027-2032)
  9. 9.5 Europe Oligonucleotide Pool Library Revenue Share by Application (2021-2032)
  10. 9.6 Europe Oligonucleotide Pool Library Revenue by Country
  11. 9.6.1 Europe Oligonucleotide Pool Library Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Oligonucleotide Pool Library Revenue by Country (2021-2026)
  13. 9.6.3 Europe Oligonucleotide Pool Library Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Oligonucleotide Pool Library Revenue (2021-2032)
  2. 10.2 China Oligonucleotide Pool Library Revenue by Type (2021-2032)
  3. 10.2.1 China Oligonucleotide Pool Library Revenue by Type (2021-2026)
  4. 10.2.2 China Oligonucleotide Pool Library Revenue by Type (2027-2032)
  5. 10.3 China Oligonucleotide Pool Library Revenue Share by Type (2021-2032)
  6. 10.4 China Oligonucleotide Pool Library Revenue by Application (2021-2032)
  7. 10.4.1 China Oligonucleotide Pool Library Revenue by Application (2021-2026)
  8. 10.4.2 China Oligonucleotide Pool Library Revenue by Application (2027-2032)
  9. 10.5 China Oligonucleotide Pool Library Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Oligonucleotide Pool Library Revenue (2021-2032)
  2. 11.2 Asia Oligonucleotide Pool Library Revenue by Type (2021-2032)
  3. 11.2.1 Asia Oligonucleotide Pool Library Revenue by Type (2021-2026)
  4. 11.2.2 Asia Oligonucleotide Pool Library Revenue by Type (2027-2032)
  5. 11.3 Asia Oligonucleotide Pool Library Revenue Share by Type (2021-2032)
  6. 11.4 Asia Oligonucleotide Pool Library Revenue by Application (2021-2032)
  7. 11.4.1 Asia Oligonucleotide Pool Library Revenue by Application (2021-2026)
  8. 11.4.2 Asia Oligonucleotide Pool Library Revenue by Application (2027-2032)
  9. 11.5 Asia Oligonucleotide Pool Library Revenue Share by Application (2021-2032)
  10. 11.6 Asia Oligonucleotide Pool Library Revenue by Country
  11. 11.6.1 Asia Oligonucleotide Pool Library Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Oligonucleotide Pool Library Revenue by Country (2021-2026)
  13. 11.6.3 Asia Oligonucleotide Pool Library Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Oligonucleotide Pool Library Revenue (2021-2032)
  2. 12.2 SAMEA Oligonucleotide Pool Library Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Oligonucleotide Pool Library Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Oligonucleotide Pool Library Revenue by Type (2027-2032)
  5. 12.3 SAMEA Oligonucleotide Pool Library Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Oligonucleotide Pool Library Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Oligonucleotide Pool Library Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Oligonucleotide Pool Library Revenue by Application (2027-2032)
  9. 12.5 SAMEA Oligonucleotide Pool Library Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Oligonucleotide Pool Library Revenue by Country
  11. 12.6.1 SAMEA Oligonucleotide Pool Library Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Oligonucleotide Pool Library Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Oligonucleotide Pool Library Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst